New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
89bio, Inc.
ETNB
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

823M

Biotechnology

Next Earning date - 13 Nov 2024

823M

Biotechnology

Next Earning date - 13 Nov 2024

7.77USD
Shape-0.04 ( -0.51%)
favorite-chart

Relative Strenght

9
favorite-chart

Volume Buzz

-51%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

53%

Quote Panel

Shape
Updated October 25, 2024
1W -4.31 % 1M 5.71 % 3M -15.80 % 1Y 13.25 %

Key Metrics

Shape
  • Market Cap

    822.92M


  • Shares Outstanding

    105.91M


  • Share in Float

    99.24M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    7.77


  • Average Volume

    560987


  • Beta

    0.987


  • Range

    6.6-16.63


  • Industry

    Biotechnology


  • Website

    https://www.89bio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3534.86x

P/S Ratio

1.51x

P/B Ratio

0.1

Debt/Equity

-74620.5%

Net Margin

$-2.0

EPS

How ETNB compares to sector?

P/E Ratio

Relative Strength

Shape

ETNB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3M

ShapeNaN%

2025-Revenue

$2.65

Shape-452%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Raymond James

upgrade

Previous: Not converted

2022-05-12

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.57
vs -1.41

Q4.22

arrow
arrow

N/A

-0.48
vs -1.30

Q1.23

arrow
arrow

N/A

-0.54
vs -1.26

Q2.23

arrow
arrow

N/A

-0.52
vs -1.23

Q3.23

arrow
arrow

N/A

-0.45
vs -0.57

Q4.23

arrow
arrow

N/A

-0.50
vs -0.48

Q1.24

arrow
arrow

N/A

-0.54
vs -0.54

Q2.24

arrow
arrow

N/A

-0.48
vs -0.52

Q3.24

arrow
arrow

N/A

-0.62
vs -0.45

Q4.24

arrow
arrow

N/A

-0.57
vs -0.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

234K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

750K  vs NA

Q4.24

arrow
arrow

+221%

750K  vs 234K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-18%

-0.18
vs -0.32

Q4.22

arrow
arrow

-16%

-0.16
vs -0.18

Q1.23

arrow
arrow

-19%

-0.19
vs -0.16

Q2.23

arrow
arrow

-9%

-0.09
vs -0.19

Q3.23

arrow
arrow

-8%

-0.08
vs -0.09

Q4.23

arrow
arrow

-8%

-0.08
vs -0.08

Q1.24

arrow
arrow

-10%

-0.10
vs -0.08

Q2.24

arrow
arrow

-9%

-0.09
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

90

90
vs 70

29%

Q4.22

arrow
arrow

117

117
vs 90

30%

Q1.23

arrow
arrow

174

174
vs 117

49%

Q2.23

arrow
arrow

168

168
vs 174

-3%

Q3.23

arrow
arrow

182

182
vs 168

8%

Q4.23

arrow
arrow

158

158
vs 182

-13%

Q1.24

arrow
arrow

160

160
vs 158

1%

Q2.24

arrow
arrow

150

150
vs 160

-6%

Earnings Growth

Latest News